Not checked for notices yet.
Rational Design of Novel Anticancer Small-Molecule RNA m6A Demethylase ALKBH5 Inhibitors
Simona Selberg, Neinar Seli, Esko Kankuri and 1 more
ACS Omega · 2021
Cited by papers we hold 6
- RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy · 2024No notice
- Epigenetics-targeted drugs: current paradigms and future challenges · 2024No notice
- Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets · 2023No notice
- m6A modification: recent advances, anticancer targeted drug discovery and beyond · 2022No notice
- RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential · 2022No notice
- Targeting the RNA m6A modification for cancer immunotherapy · 2022No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.